Results 131 to 140 of about 940,251 (149)

Demonstration of the existence of a second, non-lysosomal glucocerebrosidase that is not deficient in Gaucher disease

Biochimica Et Biophysica Acta - Molecular Basis of Disease, 1993
In addition to the lysosomal glucocerebrosidase, a distinct beta-glucosidase that is also active towards glucosylceramide could be demonstrated in various human tissues and cell types.
Johannes Aerts, Joseph M Tager, Anneke Strijland   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease.

Brain, 2014
Nahid Tayebi, Ellen Sidransky, Woojin Scott Kim   +2 more
exaly  

Glucocerebrosidase is present in α-synuclein inclusions in Lewy body disorders

Acta Neuropathologica, 2010
Ellen Sidransky, Barbara K Stubblefield, Benoit I Giasson   +2 more
exaly  

Glucocerebrosidase mutations in subjects with parkinsonism

Molecular Genetics and Metabolism, 2004
Ellen Sidransky, Özlem Göker-Alpan
exaly  

Glucocerebrosidase is shaking up the synucleinopathies

Brain, 2014
Ellen Sidransky, Marina Siebert, Wendy Westbroek   +2 more
exaly  

Association between Parkinson's disease and glucocerebrosidase mutations in Brazil

Parkinsonism and Related Disorders, 2008
Mariana Spitz, Lygia Veiga Pereira, Roberto Rozenberg   +2 more
exaly  

Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?

Molecular Genetics and Metabolism, 2003
M E Lamarca, N Tayebi, B Bembi
exaly  

Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells

Brain, 2014
Atul C Mehta, Alisdair McNeill, Matthew E Gegg   +2 more
exaly  

Glucocerebrosidase mutations in a Serbian Parkinson's disease population

European Journal of Neurology, 2013
Nikola Kresojevic, Anne Grünewald, Kishore R Kumar   +2 more
exaly  

Glucocerebrosidase mutations confer a greater risk of dementia during Parkinson's disease course†‡§

Movement Disorders, 2012
Daniel Grinberg, Henry Houlden, John Anthony Hardy   +2 more
exaly